ATE79028T1 - Nystatin enthaltende liposome. - Google Patents
Nystatin enthaltende liposome.Info
- Publication number
- ATE79028T1 ATE79028T1 AT88903033T AT88903033T ATE79028T1 AT E79028 T1 ATE79028 T1 AT E79028T1 AT 88903033 T AT88903033 T AT 88903033T AT 88903033 T AT88903033 T AT 88903033T AT E79028 T1 ATE79028 T1 AT E79028T1
- Authority
- AT
- Austria
- Prior art keywords
- nystatin
- liposome
- animal
- fungal infection
- lipids
- Prior art date
Links
- 239000002502 liposome Substances 0.000 title abstract 8
- 229960000988 nystatin Drugs 0.000 title abstract 8
- VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 title abstract 8
- 238000000034 method Methods 0.000 abstract 5
- 208000037026 Invasive Fungal Infections Diseases 0.000 abstract 4
- 150000002632 lipids Chemical class 0.000 abstract 3
- CITHEXJVPOWHKC-UUWRZZSWSA-N 1,2-di-O-myristoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCC CITHEXJVPOWHKC-UUWRZZSWSA-N 0.000 abstract 2
- PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 abstract 2
- ATBOMIWRCZXYSZ-XZBBILGWSA-N [1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (9e,12e)-octadeca-9,12-dienoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCC\C=C\C\C=C\CCCCC ATBOMIWRCZXYSZ-XZBBILGWSA-N 0.000 abstract 2
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 abstract 2
- 230000037396 body weight Effects 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 2
- 229960003724 dimyristoylphosphatidylcholine Drugs 0.000 abstract 2
- 229960005160 dimyristoylphosphatidylglycerol Drugs 0.000 abstract 2
- BPHQZTVXXXJVHI-AJQTZOPKSA-N ditetradecanoyl phosphatidylglycerol Chemical compound CCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@@H](O)CO)OC(=O)CCCCCCCCCCCCC BPHQZTVXXXJVHI-AJQTZOPKSA-N 0.000 abstract 2
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 abstract 2
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 abstract 1
- 241000233866 Fungi Species 0.000 abstract 1
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 abstract 1
- 229930182558 Sterol Natural products 0.000 abstract 1
- 230000000843 anti-fungal effect Effects 0.000 abstract 1
- 229940121375 antifungal agent Drugs 0.000 abstract 1
- 235000012000 cholesterol Nutrition 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000004291 polyenes Chemical class 0.000 abstract 1
- 150000003408 sphingolipids Chemical class 0.000 abstract 1
- 150000003432 sterols Chemical class 0.000 abstract 1
- 235000003702 sterols Nutrition 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2984—Microcapsule with fluid core [includes liposome]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/021,367 US4812312A (en) | 1987-03-03 | 1987-03-03 | Liposome-incorporated nystatin |
| EP88903033A EP0348431B1 (de) | 1987-03-03 | 1988-03-02 | Nystatin enthaltende liposome |
| PCT/US1988/000632 WO1988006440A2 (en) | 1987-03-03 | 1988-03-02 | Liposome-incorporated nystatin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE79028T1 true ATE79028T1 (de) | 1992-08-15 |
Family
ID=21803795
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT88903033T ATE79028T1 (de) | 1987-03-03 | 1988-03-02 | Nystatin enthaltende liposome. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4812312A (de) |
| EP (1) | EP0348431B1 (de) |
| JP (1) | JP2703594B2 (de) |
| AT (1) | ATE79028T1 (de) |
| AU (1) | AU1491788A (de) |
| DE (1) | DE3873528T2 (de) |
| WO (1) | WO1988006440A2 (de) |
Families Citing this family (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE60901B1 (en) * | 1986-08-21 | 1994-08-24 | Vestar Inc | Improved treatment of systemic fungal infections with phospholipid particles encapsulating polyene antifungal antibiotics |
| US5616334A (en) * | 1987-03-05 | 1997-04-01 | The Liposome Company, Inc. | Low toxicity drug-lipid systems |
| US6406713B1 (en) | 1987-03-05 | 2002-06-18 | The Liposome Company, Inc. | Methods of preparing low-toxicity drug-lipid complexes |
| US5811119A (en) * | 1987-05-19 | 1998-09-22 | Board Of Regents, The University Of Texas | Formulation and use of carotenoids in treatment of cancer |
| US4950432A (en) * | 1987-10-16 | 1990-08-21 | Board Of Regents, The University Of Texas System | Polyene microlide pre-liposomal powders |
| US5178875A (en) * | 1991-01-14 | 1993-01-12 | The Board Of Regents, The University Of Texas System | Liposomal-polyene preliposomal powder and method for its preparation |
| US5830498A (en) * | 1987-10-16 | 1998-11-03 | Board Of Regents, The University Of Texas System | Liposomal-polyene preliposomal powder and method for its preparation |
| US4981690A (en) * | 1987-10-27 | 1991-01-01 | Board Of Regents, The University Of Texas System | Liposome-incorporated mepartricin |
| WO1989006654A1 (en) * | 1988-01-19 | 1989-07-27 | Board Of Regents, The University Of Texas System | Glycosides, liposomal compositions thereof, and methods for their use |
| US4999199A (en) * | 1988-11-10 | 1991-03-12 | Board Of Regents, The University Of Texas System | Pharmaceutical formulations: liposomes incorporating aromatic polyene antibiotics |
| US5077057A (en) * | 1989-04-05 | 1991-12-31 | The Regents Of The University Of California | Preparation of liposome and lipid complex compositions |
| US5277914A (en) * | 1989-03-31 | 1994-01-11 | The Regents Of The University Of California | Preparation of liposome and lipid complex compositions |
| ATE137403T1 (de) * | 1989-03-31 | 1996-05-15 | Univ California | Zubereitung von liposomen- und lipid- komplexzusammensetzungen |
| US5549910A (en) * | 1989-03-31 | 1996-08-27 | The Regents Of The University Of California | Preparation of liposome and lipid complex compositions |
| AU6428890A (en) * | 1989-09-12 | 1991-04-18 | Regents Of The University Of California, The | Therapeutic peptides and proteins |
| IT1240354B (it) * | 1990-03-30 | 1993-12-07 | Poli Ind Chimica Spa | Formulazioni liposomiali di farmaci antimicotici,antibatterici e/o antantiflogistici per applicazione locale e vaginale |
| US5670350A (en) * | 1990-08-20 | 1997-09-23 | Novartis Finance Corporation | Genomic DNA encoding a pseudomonas global transcriptional activation element and its use in activating gene expression |
| US5662898A (en) * | 1990-08-20 | 1997-09-02 | Ciba-Geigy Corporation | Genes for the synthesis of antipathogenic substances |
| EP0567559A1 (de) * | 1991-01-14 | 1993-11-03 | The United States Of America | Anti-hiv-aktivität von liposomalem nystatin und amphotericin-b |
| US5683714A (en) * | 1991-04-19 | 1997-11-04 | Nexstar Pharmaceuticals, Inc. | Liposomal cyclosporin pharmaceutical formulation |
| US5270052A (en) * | 1991-04-19 | 1993-12-14 | New England Medical Center Hospitals, Inc. | Methods and compositions for treatment of infection by intracellular parasites |
| GB9111611D0 (en) * | 1991-05-30 | 1991-07-24 | Sandoz Ltd | Liposomes |
| US5552156A (en) * | 1992-10-23 | 1996-09-03 | Ohio State University | Liposomal and micellular stabilization of camptothecin drugs |
| DE69434623T2 (de) | 1993-09-29 | 2006-07-27 | Dsm Ip Assets B.V. | Modifizierte Formen des Natamycins, Verfahren zu ihrer Herstellung und sie enthaltende antifungale Zusammensetzungen |
| US5736156A (en) * | 1995-03-22 | 1998-04-07 | The Ohio State University | Liposomal anf micellular stabilization of camptothecin drugs |
| US5902604A (en) | 1995-06-06 | 1999-05-11 | Board Of Regents, The University Of Texas System | Submicron liposome suspensions obtained from preliposome lyophilizates |
| US5693336A (en) * | 1995-06-07 | 1997-12-02 | Nexstar Pharmaceuticals, Inc. | Blood stable liposomal cyclosporin formulations |
| US6071535A (en) * | 1996-01-31 | 2000-06-06 | Collaborative Laboratories, Inc. | Lipid vesicles formed with alkylammonium fatty acid salts |
| US5874105A (en) * | 1996-01-31 | 1999-02-23 | Collaborative Laboratories, Inc. | Lipid vesicles formed with alkylammonium fatty acid salts |
| US6183774B1 (en) | 1996-01-31 | 2001-02-06 | Collaborative Laboratories, Inc. | Stabilizing vitamin A derivatives by encapsulation in lipid vesicles formed with alkylammonium fatty acid salts |
| US5935572A (en) * | 1997-01-10 | 1999-08-10 | Collaborative Laboratories, Inc. | Composition containing protease separate from glycosidase for removing nits in treating lice infestation |
| CA2279259A1 (en) * | 1997-02-04 | 1998-08-06 | Abbott Laboratories | Pain reducing parenteral liposome formulation |
| US6613352B2 (en) * | 1999-04-13 | 2003-09-02 | Universite De Montreal | Low-rigidity liposomal formulation |
| US6413537B1 (en) | 2000-03-10 | 2002-07-02 | Wisconsin Alumni Research Foundation | Nystatin formulation having reduced toxicity |
| WO2002058622A2 (en) * | 2000-11-09 | 2002-08-01 | Neopharm, Inc. | Sn-38 lipid complexes and methods of use |
| WO2003030864A1 (en) * | 2001-05-29 | 2003-04-17 | Neopharm, Inc. | Liposomal formulation of irinotecan |
| US20060030578A1 (en) * | 2002-08-20 | 2006-02-09 | Neopharm, Inc. | Pharmaceutically active lipid based formulation of irinotecan |
| AU2003296897A1 (en) * | 2002-08-20 | 2004-05-04 | Neopharm, Inc. | Pharmaceutical formulations of camptothecine derivatives |
| KR100651728B1 (ko) * | 2004-11-10 | 2006-12-06 | 한국전자통신연구원 | 정착기를 갖는 전자 소자용 화합물 및 이를 포함하는 전자소자와 이들의 제조 방법 |
| US8895717B2 (en) | 2005-04-15 | 2014-11-25 | The Board Of Regents Of The University Of Texas System | Delivery of siRNA by neutral lipid compositions |
| US9393198B2 (en) * | 2010-03-22 | 2016-07-19 | Signpath Pharma Inc. | Intravenous curcumin and derivatives for treatment of neurodegenerative and stress disorders |
| CN102698270B (zh) * | 2011-03-28 | 2016-02-03 | 清华大学 | 一种增强靶细胞摄取治疗剂的方法和药物组合物 |
| US12004868B2 (en) | 2011-06-03 | 2024-06-11 | Signpath Pharma Inc. | Liposomal mitigation of drug-induced inhibition of the cardiac IKr channel |
| US10449193B2 (en) | 2011-06-03 | 2019-10-22 | Signpath Pharma Inc. | Protective effect of DMPC, DMPG, DMPC/DMPG, lysoPG and lysoPC against drugs that cause channelopathies |
| US10117881B2 (en) | 2011-06-03 | 2018-11-06 | Signpath Pharma, Inc. | Protective effect of DMPC, DMPG, DMPC/DMPG, LYSOPG and LYSOPC against drugs that cause channelopathies |
| GB2507884B (en) * | 2011-06-03 | 2019-10-23 | Signpath Pharma Inc | Liposomal mitigation of drug-induced long QT syndrome and potassium delayed-rectifier current |
| US10349884B2 (en) | 2011-06-03 | 2019-07-16 | Sighpath Pharma Inc. | Liposomal mitigation of drug-induced inhibition of the cardiac ikr channel |
| US10238602B2 (en) | 2011-06-03 | 2019-03-26 | Signpath Pharma, Inc. | Protective effect of DMPC, DMPG, DMPC/DMPG, LysoPG and LysoPC against drugs that cause channelopathies |
| US9744191B2 (en) | 2012-03-19 | 2017-08-29 | Yale University | Antimicrobial compositions and methods |
| CA2882978A1 (en) | 2012-08-31 | 2014-03-06 | Signpath Pharma Inc. | Curcumin-er, a liposomal-plga sustained release nanocurcumin for minimizing qt prolongation for cancer therapy |
| US20150147382A1 (en) * | 2013-09-23 | 2015-05-28 | Exir Nano Sina Company | Topical liposomal compositions for delivering hydrophobic drugs and methods preparing same |
| CA2933204C (en) | 2013-12-18 | 2020-04-28 | Signpath Pharma, Inc. | Liposomal mitigation of drug-induced inhibition of the cardiac ikr channel |
| US11806401B2 (en) | 2016-04-27 | 2023-11-07 | Signpath Pharma, Inc. | Prevention of drug-induced atrio-ventricular block |
| MX2019005141A (es) * | 2016-11-09 | 2019-09-26 | Signpath Pharma Inc | Efecto protector de dmpc, dmpg, dmpc/dmpg, lisopg y lisopc contra fármacos que causan canalopatías. |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4235871A (en) * | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
| US4186183A (en) * | 1978-03-29 | 1980-01-29 | The United States Of America As Represented By The Secretary Of The Army | Liposome carriers in chemotherapy of leishmaniasis |
| JPS5622724A (en) * | 1979-08-02 | 1981-03-03 | Asahi Chem Ind Co Ltd | Pharmaceutical preparation of n4-acylcytosine arabinoside |
| JPS59500952A (ja) * | 1982-03-29 | 1984-05-31 | ザ リポソ−ム カンパニ−、インコ−ポレ−テッド | 安定なプルリラメラベシクル類 |
| US4515736A (en) * | 1983-05-12 | 1985-05-07 | The Regents Of The University Of California | Method for encapsulating materials into liposomes |
| US4766046A (en) * | 1985-09-27 | 1988-08-23 | Liposome Technology, Inc. | Stabilized liposome/amphotericin composition and method |
| IE60901B1 (en) * | 1986-08-21 | 1994-08-24 | Vestar Inc | Improved treatment of systemic fungal infections with phospholipid particles encapsulating polyene antifungal antibiotics |
-
1987
- 1987-03-03 US US07/021,367 patent/US4812312A/en not_active Expired - Lifetime
-
1988
- 1988-03-02 WO PCT/US1988/000632 patent/WO1988006440A2/en not_active Ceased
- 1988-03-02 AU AU14917/88A patent/AU1491788A/en not_active Abandoned
- 1988-03-02 JP JP63502721A patent/JP2703594B2/ja not_active Expired - Fee Related
- 1988-03-02 EP EP88903033A patent/EP0348431B1/de not_active Expired - Lifetime
- 1988-03-02 AT AT88903033T patent/ATE79028T1/de not_active IP Right Cessation
- 1988-03-02 DE DE8888903033T patent/DE3873528T2/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE3873528T2 (de) | 1993-01-21 |
| EP0348431B1 (de) | 1992-08-05 |
| WO1988006440A2 (en) | 1988-09-07 |
| EP0348431A1 (de) | 1990-01-03 |
| DE3873528D1 (de) | 1992-09-10 |
| WO1988006440A3 (en) | 1988-10-20 |
| AU1491788A (en) | 1988-09-26 |
| JPH02502459A (ja) | 1990-08-09 |
| US4812312A (en) | 1989-03-14 |
| JP2703594B2 (ja) | 1998-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE79028T1 (de) | Nystatin enthaltende liposome. | |
| Touitou et al. | Liposomes as carriers for topical and transdermal delivery | |
| AU754559B2 (en) | Liposomal bupivacaine compositions prepared using an ammonium sulfate gradient | |
| Calissano et al. | Effect of two brain specific proteins (S100 and 14.3. 2) on cation diffusion across artificial lipid membranes | |
| Planas et al. | Noninvasive percutaneous induction of topical analgesia by a new type of drug carrier, and prolongation of local pain insensitivity by anesthetic liposomes | |
| CA2233961A1 (en) | Stimulation of hair follicles | |
| KR890007718A (ko) | 개선된 암포테리신b 리포좀 제조법 | |
| BR1100687A (pt) | Formulações de agentes antineoplásticos lipossÈmicos com proporção elevada de droga com lipìdio | |
| DK434187A (da) | Injektionspraeparat omfattende i phospholipidpartikler indkapslede antifungale polyen-antibiotika | |
| NZ297364A (en) | Soft antibacterial liposomes of neutral & anionic phospholipids | |
| CA1262334C (en) | STEROID LIPOSOMES | |
| AU2427601A (en) | Radiation sensitive liposomes | |
| Frézard et al. | Permeability and stability in buffer and in human serum of fluorinated phospholipid-based liposomes | |
| CA2280253A1 (en) | Use of 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzoquinone | |
| AU7343894A (en) | Biphasic multilamellar lipid vesicles | |
| CA2117769A1 (en) | Liposome composition | |
| Jullien et al. | Study of the effects of liposomal amphotericin B on Candida albicans, Cryptococcus neoformans, and erythrocytes by using small unilamellar vesicles prepared from saturated phospholipids | |
| ES2086802T3 (es) | Formulaciones liposomicas de principios activos y procedimiento para su preparacion. | |
| Di Giulio et al. | Encapsulation of ampicillin in reverse-phase evaporation liposomes: a direct evaluation by derivative spectrophotometry | |
| De Logu et al. | Effects of in-vitro activity of miconazole and ketoconazole in phospholipid formulations. | |
| GB2143433A (en) | Methotrexate ointment | |
| Wertz | Liposome dermatics: Chemical aspects of the skin lipid approach | |
| AU2001276254B2 (en) | Liposomic formulation of clobetasol propionate | |
| Szebeni et al. | Factors influencing the in vitro stability of artificial red blood cells based on hemoglobin-containing liposomes | |
| WO2003000232A3 (en) | Method for preparation of vesicles loaded with immunostimulator y oligodeoxynucleotides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |